Corindus Vascular Robotics
Waltham developer of the CorPath robotic system for vascular interventions, acquired by Siemens Healthineers in 2019.
Corindus Vascular Robotics built robotic systems that let physicians steer guide catheters, guidewires, balloons and stents during vascular procedures, with its CorPath GRX platform cleared by the FDA for percutaneous coronary interventions. The company was based in Waltham, Massachusetts, and traded on NYSE MKT as CVRS. In September 2014 it agreed to sell 10,666,570 shares at $2.50 in a private placement worth $26,666,425 gross, with Stifel and Cowen as placement agents, and the closing was still pending when it filed its report. In March 2017 it closed a private placement of 68,055,700 shares at $0.6616 for about $45 million gross; new backers included Boston Scientific, BioStar Ventures, Consonance Capital and Hudson Executive Capital, with HealthCor and Royal Philips also investing again. In August 2019 Corindus agreed to be bought by Siemens Healthineers for $4.28 per share in cash, a deal valued at about $1.1 billion, and Siemens Healthineers completed the purchase of all shares on October 29, 2019.
- Latest funding
- $45M
- Total funding
- $45M
- Latest valuation
- —
- Founded
- —
- Country
- United States
- Mar 16, 2017Private placement$45M
- Sep 12, 2014Private placement—